Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Post-COVID-19 Smell Disorders
NCT05395845Phase 1Unknown
- Start
- Jun 2022
- Primary completion
- Dec 2022
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
01
Overview
Phase 1, open-label, single-arm trial of platelet-rich plasma in anosmia. Primary endpoint: Change From Baseline in Loss of Smell on the Olfactory Determination Rating scale for COVID-19 (ODoR-19) at 6 weeks. Status: unknown.
02
Drugs
platelet-rich plasma
03
Conditions
anosmia
Beyond the preview
Go deeper on NCT05395845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05395845.